11/7/26 Myth-Busting Hybrid & Home-Based Trials: What’s Real, What’s Not and What Scales Previous Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale Next One Shot, No Slack: The Clinical Decisions That Make or Break a Rare Disease Program You Might Also Like Designing Neuromuscular Trials for Successful Execution: The Role of Specialized CROs, Sites and Clinical Research Vendors From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Ultra-Rare, Ultra-Lean: Designing for a Viable ROI Under 1,000 Patients From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle Leveraging Natural History and RWE for Rare Approvals
11/7/26 Myth-Busting Hybrid & Home-Based Trials: What’s Real, What’s Not and What Scales Previous Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale Next One Shot, No Slack: The Clinical Decisions That Make or Break a Rare Disease Program You Might Also Like Designing Neuromuscular Trials for Successful Execution: The Role of Specialized CROs, Sites and Clinical Research Vendors From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Ultra-Rare, Ultra-Lean: Designing for a Viable ROI Under 1,000 Patients From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle Leveraging Natural History and RWE for Rare Approvals
